Athulya Senior Care Inks MoU with SingHealth to Advance Senior Care, Training, and Research Collaboration

IMT News Desk
IMT News Desk
· 2 min read
Athulya Senior Care signs MoU with SingHealth for senior care collaboration.

Athulya Senior Care has signed a Memorandum of Understanding (MoU) with SingHealth, Singapore’s largest public healthcare cluster, to collaborate on medical services, professional training, research, and knowledge exchange amid rising demand from ageing populations.

SingHealth’s network includes Singapore General Hospital, KK Women’s and Children’s Hospital, Changi General Hospital, Sengkang General Hospital, and national centres like the National Cancer Centre Singapore, National Heart Centre Singapore, National Neuroscience Institute, alongside polyclinics and community hospitals.

The partnership merges Athulya’s senior living expertise with SingHealth’s clinical and academic strengths to enhance care delivery and institutional capacity. Planned initiatives include annual training for doctors, nurses, and allied professionals; exchange of scientific materials; joint R&D and publications; and participation in conferences, workshops, and bilateral meetings.

Mr. Srinivasan G, CEO & Founder, Athulya Senior Care, said: “This collaboration with SingHealth represents an important milestone in our journey to enhance senior care in India. By integrating Athulya’s care delivery experience with SingHealth’s clinical expertise, we aim to further strengthen our capabilities across medical services, training, and research.”

Ms. Vijaya Rao, Director, International Collaboration Office, SingHealth, added: “We are pleased to collaborate with Athulya Senior Care in exploring opportunities to advance medical services, education, and research. This partnership underscores our commitment to international collaboration and knowledge exchange.”

Mr. London Lucien Ooi, Group Director, International Collaboration Office, SingHealth, noted: “This collaboration reflects SingHealth’s ongoing commitment to building meaningful international partnerships that drive the exchange of knowledge, clinical expertise, and best practices.”

The MoU lays the foundation for sustained engagement to elevate senior care standards, professional development, and research innovation across both organisations.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk